Use of prescription contraception remains lower among privately insured women with HIV infection compared to noninfected women in the US, particularly among those receiving antiretroviral therapy, a recent study found. The study used a large US nationwide health care claims database to identify girls and women aged 15 to 55 years with prescription drug coverage and calculated prevalence of contraceptive use by HIV infection status, and by use of antiretroviral therapy among those with HIV. Researchers found:
- While contraceptive use increased among HIV-infected and noninfected women from 2008 through 2014, a lower proportion of HIV-infected women used prescription contraceptive methods in both years.
- HIV-infected women had lower odds of using long-acting reversible contraception compared with HIV-noninfected women (adjusted odds ratio, 0.67) or short-acting hormonal contraception method (aOR, 0.59).
- Those receiving antiretroviral therapy had lower odds of using short-acting hormonal contraception compared to no method.
- There was no significant difference in female sterilization by HIV status or antiretroviral therapy use.
Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ. Trends in contraceptive use according to HIV status among privately insured women in the United States. [Published online ahead of print August 30, 2017]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2017.08.006.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al